AAD 2026Abstract 76651
Real-World Use of the Topical HSV-1-Based Gene Therapy B-VEC by Dominant Dystrophic Epidermolysis Bullosa Patients
Agostini B, Mailliard S, Ledbetter T, Fitzgerald K, Krishnan S
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Infections & infestationsGenetic skin disease
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1503 · Not in PubMed: details from Crossref